ASV Therapy for Insomnia

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorResMed

About this trial

This will be a single center, prospective study designed to evaluate the effect of adaptive servo ventilation therapy on insomnia severity among patients with moderate to severe chronic insomnia.

Eligibility criteria

Qualifiers

≥ 18 years old

Complaint of insomnia when presenting at clinic

Diagnosis of moderate to severe insomnia through the Insomnia Severity Index (ISI) with a score ≥ 15

Meet diagnostic criteria of Insomnia Disorder (per American Academy of Sleep Medicine)

Disqualifiers

Primary complaint of sleep-disordered breathing or issues with apneas during sleep or excessive daytime sleepiness

Pregnant or planning to be pregnant

Any prior diagnosis of severe respiratory disorder or severe sleep disorder such as restless leg syndrome (RLS), idiopathic hypersomnia, or narcolepsy

High risk for moderate to severe OSA based on STOP-BANG score.

Trial design

Treatments tested in this trial

  • ASV therapy

Treatment groups

25 Participants
are divided into 1 treatment group

Sponsors and collaborators